Lanxi Song

4.7k total citations · 2 hit papers
23 papers, 3.9k citations indexed

About

Lanxi Song is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lanxi Song has authored 23 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lanxi Song's work include Lung Cancer Treatments and Mutations (10 papers), Cytokine Signaling Pathways and Interactions (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Lanxi Song is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Cytokine Signaling Pathways and Interactions (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Lanxi Song collaborates with scholars based in United States, Austria and Japan. Lanxi Song's co-authors include Eric B. Haura, Richard Jove, James Turkson, James G. Karras, Domenico Coppola, Dominic Sinibaldi, Richard Heller, Lee M. Ellis, Jacqueline Bromberg and Drew M. Pardoll and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lanxi Song

23 papers receiving 3.8k citations

Hit Papers

Constitutive Stat3 activity up-regulates VEGF expression ... 2002 2026 2010 2018 2002 2009 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
    2002 1.0k citations Guilian Niu, Kenneth L. Wright et al. Oncogene profile →
  2. Src kinases as therapeutic targets for cancer
    2009 569 citations Lanxi Song, Eric B. Haura et al. Nature Reviews Clinical Oncology profile →

Peers

Lanxi Song
Stefano Pepe Italy
Jennifer R. Grandis United States
Kuen‐Feng Chen Taiwan
William H. Chappell United States
Sarki A. Abdulkadir United States
Joseph A. Fontana United States
Ralf Buettner United States
Deborah A. Altomare United States
Pixu Liu China
Anthony C. Faber United States
Stefano Pepe Italy
Lanxi Song
Citations per year, relative to Lanxi Song Lanxi Song (= 1×) peers Stefano Pepe

Countries citing papers authored by Lanxi Song

Since Specialization
Citations

This map shows the geographic impact of Lanxi Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanxi Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanxi Song more than expected).

Fields of papers citing papers by Lanxi Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanxi Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanxi Song. The network helps show where Lanxi Song may publish in the future.

Co-authorship network of co-authors of Lanxi Song

This figure shows the co-authorship network connecting the top 25 collaborators of Lanxi Song. A scholar is included among the top collaborators of Lanxi Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanxi Song. Lanxi Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Guolin, Jihye Kim, Andrii I. Rozhok, et al.. (2016). Coupling an EML4-ALK–centric interactome with RNA interference identifies sensitizers to ALK inhibitors. Science Signaling. 9(450). rs12–rs12. 24 indexed citations
2.
Gridling, Manuela, Scott B. Ficarro, Florian P. Breitwieser, et al.. (2014). Identification of Kinase Inhibitor Targets in the Lung Cancer Microenvironment by Chemical and Phosphoproteomics. Molecular Cancer Therapeutics. 13(11). 2751–2762. 20 indexed citations
3.
Bai, Yun, Jae‐Young Kim, Bin Fang, et al.. (2014). Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations. Cancer Research. 74(24). 7217–7228. 34 indexed citations
4.
Song, Lanxi, Matthew A. Smith, Parul Doshi, et al.. (2014). Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer. Journal of Thoracic Oncology. 9(7). 974–982. 85 indexed citations
5.
Alexandrow, Mark G., et al.. (2011). Curcumin. European Journal of Cancer Prevention. 21(5). 407–412. 98 indexed citations
6.
Song, Lanxi, Bhupendra Rawal, Jeffrey A. Nemeth, & Eric B. Haura. (2011). JAK1 Activates STAT3 Activity in Non-Small–Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling. Molecular Cancer Therapeutics. 10(3). 481–494. 140 indexed citations
7.
Li, Jiannong, Uwe Rix, Bin Fang, et al.. (2010). A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nature Chemical Biology. 6(4). 291–299. 219 indexed citations
8.
Haura, Eric B., et al.. (2010). A Pilot Study of Preoperative Gefitinib for Early-Stage Lung Cancer to Assess Intratumor Drug Concentration and Pathways Mediating Primary Resistance. Journal of Thoracic Oncology. 5(11). 1806–1814. 47 indexed citations
9.
Song, Lanxi, et al.. (2009). Src kinases as therapeutic targets for cancer. Nature Reviews Clinical Oncology. 6(10). 587–595. 569 indexed citations breakdown →
10.
Li, Jiannong, Bin Yu, Lanxi Song, Steven A. Eschrich, & Eric B. Haura. (2007). Effects of IFN- γ And Stat1 on Gene Expression, Growth, And Survival in Non-Small Cell Lung Cancer Cells. Journal of Interferon & Cytokine Research. 27(3). 209–220. 12 indexed citations
11.
Song, Lanxi, Mark Morris, Tapan Bagui, et al.. (2006). Dasatinib (BMS-354825) Selectively Induces Apoptosis in Lung Cancer Cells Dependent on Epidermal Growth Factor Receptor Signaling for Survival. Cancer Research. 66(11). 5542–5548. 183 indexed citations
12.
Song, Lanxi, et al.. (2005). Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells. Cancer Biology & Therapy. 4(3). 267–276. 181 indexed citations
13.
Ferraro, Bernadette, Lanxi Song, Bin Yu, et al.. (2005). Stat3 regulates genes common to both wound healing and cancer. Oncogene. 24(21). 3397–3408. 320 indexed citations
14.
Haura, Eric B., Zhong Zheng, Lanxi Song, Alan Cantor, & Gerold Bepler. (2005). Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor SurvivalIn vivoin Non–Small Cell Lung Cancer. Clinical Cancer Research. 11(23). 8288–8294. 190 indexed citations
15.
Song, Lanxi, James Turkson, James G. Karras, Richard Jove, & Eric B. Haura. (2003). Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene. 22(27). 4150–4165. 315 indexed citations
16.
17.
Niu, Guilian, Kenneth L. Wright, Mei Huang, et al.. (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 21(13). 2000–2008. 1019 indexed citations breakdown →
18.
Croxton, Rhonda, Yihong Ma, Lanxi Song, Eric B. Haura, & W. Douglas Cress. (2002). Direct repression of the Mcl-1 promoter by E2F1. Oncogene. 21(9). 1359–1369. 120 indexed citations
19.
Song, Lanxi, et al.. (2001). Quercetin Inhibits Matrix Metalloproteinase-1 Expression in Human Vascular Endothelial Cells through Extracellular Signal-Regulated Kinase. Archives of Biochemistry and Biophysics. 391(1). 72–78. 38 indexed citations
20.
Huang, Yan, et al.. (2001). Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells. Atherosclerosis. 156(1). 119–125. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Pepe Breakdown of academic impact, for papers by Jennifer R. Grandis Breakdown of academic impact, for papers by Kuen‐Feng Chen Breakdown of academic impact, for papers by William H. Chappell Breakdown of academic impact, for papers by Sarki A. Abdulkadir Breakdown of academic impact, for papers by Joseph A. Fontana Breakdown of academic impact, for papers by Ralf Buettner Breakdown of academic impact, for papers by Deborah A. Altomare Breakdown of academic impact, for papers by Pixu Liu Breakdown of academic impact, for papers by Anthony C. Faber
Rankless by CCL
2026